Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523194 · ClinicalTrials.gov registry record
Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration
A clinical trial of Atherosclerosis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT04523194 is a study of Atherosclerosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 1,000 participants, roughly in line with the 1,051-participant average among 69 other Atherosclerosis trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT04523194, a study of Atherosclerosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create a resource to promote further understanding of the pathobiology of atherosclerosis through image analysis.
Conditions Studied
Interventions
- OTHER Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA)
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Other
- Tsuchiura Kyodo General Hospital - Tsuchiura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04523194
The ClinicalTrials.gov registry entry for NCT04523194 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,051-participant average among 69 other Atherosclerosis trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 1 intervention - of which Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA) is the first listed.
NCT04523194 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT04523194 about?
NCT04523194 is a clinical study titled "Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration". The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create ...
What is the current status of trial NCT04523194?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2020-11-09. Estimated completion is 2027-12.
What conditions does trial NCT04523194 study?
This clinical trial studies the following conditions: Atherosclerosis.
What interventions are being tested in trial NCT04523194?
The interventions under investigation include: Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA) (OTHER).
Who is sponsoring clinical trial NCT04523194?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523194 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RECRUITING · Phase 4
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
-
Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.